Niacin and Statin Combination Therapy: Balancing HDL and LDL to Reduce Cardiovascular Risk

Please Note: This CME activity has expired. You may continue to view the material for educational purposes, but this activity is no longer eligible for CME credit.

Course Objectives:
This CME-certified monograph is intended for U.S.-based Nurse Practioners and Physician Assisstants. Upon completing this activity, you should be able to:

1. Understand the importance of raising HDL as an adjunctive approach to further reduce cardiovascular risk.
2. Describe the benefits of combination statin and niacin therapy to more effectively reduce the progression of atherosclerosis.
3. Discuss the advantages of extended-release niacin and the significant reduction in flushing and hepatotoxic adverse effects.

Accreditation:
This activity was reviewed for relevance, accuracy of content, balance of presentation, and time required for participation by Mark A. Gendreau, MD, Abigail Zavod, MD, and Alexandra Mangili, MD.

Release Date: December 2007
Expiration Date: November 30, 2009

Millennium CME Institute, Inc., is accredited by the ACCME to provide continuing medical education for physicians.
Millennium CME Institute, Inc., designates this CME-certified monograph for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This program has been approved for 1.18 contact hours of continuing education by the American Academy of Nurse Practioners. Program ID 0711514.

Faculty Disclosure:
Millennium CME Institute, Inc., endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support. All faculty are required to disclose any commercial relationships or personal benefit with companies whose products are discussed in educational presentations and with companies who have provided the commercial support for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

The faculty listed below have declared that they have no relationships to disclose:
Abigail Zavod, MD
Alexandra Mangili, MD
Mark A. Gendreau, MD
Tim I. Robinson
Frank A. Gesek, PhD, RPh
Peter B. Lindgren, PhD

The faculty listed below have declared the following arrangements and/or affiliations:
Michael H. Davidson, MD, FACC: Radiant Research, Chicago, Illinois

Directions:
The participant should read the learning objectives and review the activity in its entirety. After reviewing the material, the participant should complete the Activity Self-assessment Test consisting of a series of multiple-choice questions.
Upon successfully completing this activity as designed and achieving a passing score of 70% or higher on the Activity Self-assessment Test, participants will receive a continuing education credit letter awarding the appropriate credit and the Activity Self-assessment Test answers four to six weeks after the receipt of the registration and evaluation materials.

Estimated time to complete this CME-certified monograph as designed is 1.0 hours.

CME Testing Options